Skip to main content
Top
Published in: Inflammation 2/2017

01-04-2017 | ORIGINAL ARTICLE

Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa

Authors: S. Hessam, M. Sand, M. Skrygan, T. Gambichler, F. G. Bechara

Published in: Inflammation | Issue 2/2017

Login to get access

Abstract

Hidradenitis suppurativa (HS) has been associated with marked inflammatory perturbation. The mechanisms regulating the inflammatory network remain elusive. microRNAs (miRNAs) have been described as gene regulators of inflammation. We evaluated the messenger RNA (mRNA) expression levels of six selected inflammation-related miRNAs in lesional and perilesional skin samples of HS patients and in healthy controls. Samples of 15 HS patients and 10 healthy controls were included in this prospective study. Expression levels of the miRNAs miRNA-155-5p, miRNA-223-5p, miRNA-31-5p, miRNA-21-5p, miRNA-125b-5p, and miRNA-146a-5p were studied by quantitative real-time reverse transcription polymerase chain reaction. We observed a significant overexpression of miRNA-155-5p, miRNA-223-5p, miRNA-31-5p, miRNA-21-5p, and miRNA-146a-5p in lesional HS skin compared to healthy controls. Expression of these miRNAs was also significantly increased in lesional HS skin when compared to perilesional skin. Only miRNA-155-5p showed an increased expression in perilesional skin compared to healthy controls. In contrast, miRNA-125b-5p had a significantly lower expression in lesional HS skin compared to perilesional skin. We found that the studied inflammation-related miRNAs were significantly dysregulated in lesional HS skin and may have regulatory roles in the inflammatory process of HS. Given their predicted targets and functions, our findings point to these miRNAs as potential disease biomarkers, and manipulation might be used therapeutically to target the inflammatory pathway in HS.
Literature
2.
go back to reference Janse, I.C., J.L. Blok, G.F.H. Diercks, B. Horváth, and M.F. Jonkman. 2016. Hidradenitis suppurativa: A disease of infundibular epidermis, rather than pilosebaceous units? The British Journal of Dermatology. doi:10.1111/bjd.14992. Janse, I.C., J.L. Blok, G.F.H. Diercks, B. Horváth, and M.F. Jonkman. 2016. Hidradenitis suppurativa: A disease of infundibular epidermis, rather than pilosebaceous units? The British Journal of Dermatology. doi:10.​1111/​bjd.​14992.
5.
go back to reference Hessam, S., M. Sand, T. Gambichler, and F.G. Bechara. 2015. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS). Journal of the American Academy of Dermatology 73: 998–1005. doi:10.1016/j.jaad.2015.08.052.CrossRefPubMed Hessam, S., M. Sand, T. Gambichler, and F.G. Bechara. 2015. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS). Journal of the American Academy of Dermatology 73: 998–1005. doi:10.​1016/​j.​jaad.​2015.​08.​052.CrossRefPubMed
12.
go back to reference Hessam, S., M. Sand, M. Skrygan, T. Gambichler, and F.G. Bechara. 2016. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients. Journal of Dermatological Science. doi:10.1016/j.jdermsci.2016.02.009. Hessam, S., M. Sand, M. Skrygan, T. Gambichler, and F.G. Bechara. 2016. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients. Journal of Dermatological Science. doi:10.​1016/​j.​jdermsci.​2016.​02.​009.
15.
go back to reference Xu, N., F. Meisgen, L.M. Butler, G. Han, X.-J. Wang, C. Söderberg-Nauclér, M. Ståhle, A. Pivarcsi, and E. Sonkoly. 2013. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. Journal of Immunology (Baltimore, Md.: 1950) 190: 678–688. doi:10.4049/jimmunol.1202695.CrossRef Xu, N., F. Meisgen, L.M. Butler, G. Han, X.-J. Wang, C. Söderberg-Nauclér, M. Ståhle, A. Pivarcsi, and E. Sonkoly. 2013. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. Journal of Immunology (Baltimore, Md.: 1950) 190: 678–688. doi:10.​4049/​jimmunol.​1202695.CrossRef
16.
go back to reference Xu, N., P. Brodin, T. Wei, F. Meisgen, L. Eidsmo, N. Nagy, L. Kemeny, M. Ståhle, E. Sonkoly, and A. Pivarcsi. 2011. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. The Journal of Investigative Dermatology 131: 1521–1529. doi:10.1038/jid.2011.55.CrossRefPubMed Xu, N., P. Brodin, T. Wei, F. Meisgen, L. Eidsmo, N. Nagy, L. Kemeny, M. Ståhle, E. Sonkoly, and A. Pivarcsi. 2011. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. The Journal of Investigative Dermatology 131: 1521–1529. doi:10.​1038/​jid.​2011.​55.CrossRefPubMed
17.
go back to reference Kimball, A.B., M.M. Okun, D.A. Williams, A.B. Gottlieb, K.A. Papp, C.C. Zouboulis, A.W. Armstrong, et al. 2016. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. The New England Journal of Medicine 375: 422–434. doi:10.1056/NEJMoa1504370.CrossRefPubMed Kimball, A.B., M.M. Okun, D.A. Williams, A.B. Gottlieb, K.A. Papp, C.C. Zouboulis, A.W. Armstrong, et al. 2016. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. The New England Journal of Medicine 375: 422–434. doi:10.​1056/​NEJMoa1504370.CrossRefPubMed
18.
go back to reference Tili, E., J.-J. Michaille, A. Cimino, S. Costinean, C.D. Dumitru, B. Adair, M. Fabbri, et al. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. Journal of immunology (Baltimore, Md.: 1950) 179: 5082–5089.CrossRef Tili, E., J.-J. Michaille, A. Cimino, S. Costinean, C.D. Dumitru, B. Adair, M. Fabbri, et al. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. Journal of immunology (Baltimore, Md.: 1950) 179: 5082–5089.CrossRef
19.
go back to reference Taganov, K.D., M.P. Boldin, K.-J. Chang, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 103: 12481–12486. doi:10.1073/pnas.0605298103.CrossRefPubMedPubMedCentral Taganov, K.D., M.P. Boldin, K.-J. Chang, and D. Baltimore. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 103: 12481–12486. doi:10.​1073/​pnas.​0605298103.CrossRefPubMedPubMedCentral
20.
go back to reference Lima, A.L., I. Karl, T. Giner, H. Poppe, M. Schmidt, D. Presser, M. Goebeler, and B. Bauer. 2016. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. The British Journal of Dermatology 174: 514–521. doi:10.1111/bjd.14214.CrossRefPubMed Lima, A.L., I. Karl, T. Giner, H. Poppe, M. Schmidt, D. Presser, M. Goebeler, and B. Bauer. 2016. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. The British Journal of Dermatology 174: 514–521. doi:10.​1111/​bjd.​14214.CrossRefPubMed
21.
go back to reference van der Zee, H.H., L. de Ruiter, J. Boer, D.G. van den Broecke, J.C. den Hollander, J.D. Laman, and E.P. Prens. 2012. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. The British Journal of Dermatology 166: 98–106. doi:10.1111/j.1365-2133.2011.10643.x.CrossRefPubMed van der Zee, H.H., L. de Ruiter, J. Boer, D.G. van den Broecke, J.C. den Hollander, J.D. Laman, and E.P. Prens. 2012. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. The British Journal of Dermatology 166: 98–106. doi:10.​1111/​j.​1365-2133.​2011.​10643.​x.CrossRefPubMed
23.
go back to reference Johnnidis, J.B., M.H. Harris, R.T. Wheeler, S. Stehling-Sun, M.H. Lam, O. Kirak, T.R. Brummelkamp, M.D. Fleming, and F.D. Camargo. 2008. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125–1129. doi:10.1038/nature06607.CrossRefPubMed Johnnidis, J.B., M.H. Harris, R.T. Wheeler, S. Stehling-Sun, M.H. Lam, O. Kirak, T.R. Brummelkamp, M.D. Fleming, and F.D. Camargo. 2008. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125–1129. doi:10.​1038/​nature06607.CrossRefPubMed
24.
go back to reference Cheng, Z., L. Yan, W. Lin, W. Jiang, Y. Zhang, J. Xi, L. Chen, et al. 2014. Identification of reference miRNAs in human tumors by TCGA miRNA-seq data. Biochemical and Biophysical Research Communications 453: 375–378. doi:10.1016/j.bbrc.2014.09.086.CrossRef Cheng, Z., L. Yan, W. Lin, W. Jiang, Y. Zhang, J. Xi, L. Chen, et al. 2014. Identification of reference miRNAs in human tumors by TCGA miRNA-seq data. Biochemical and Biophysical Research Communications 453: 375–378. doi:10.​1016/​j.​bbrc.​2014.​09.​086.CrossRef
25.
go back to reference Peltier, H.J., and G.J. Latham. 2008. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA (New York, N.Y.) 14: 844–852. doi:10.1261/rna.939908.CrossRef Peltier, H.J., and G.J. Latham. 2008. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA (New York, N.Y.) 14: 844–852. doi:10.​1261/​rna.​939908.CrossRef
26.
go back to reference Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods (San Diego, Calif.) 25: 402–408. doi:10.1006/meth.2001.1262.CrossRef Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods (San Diego, Calif.) 25: 402–408. doi:10.​1006/​meth.​2001.​1262.CrossRef
27.
go back to reference Kurowska-Stolarska, M., S. Alivernini, L.E. Ballantine, D.L. Asquith, N.L. Millar, D.S. Gilchrist, J. Reilly, et al. 2011. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proceedings of the National Academy of Sciences of the United States of America 108: 11193–11198. doi:10.1073/pnas.1019536108.CrossRefPubMedPubMedCentral Kurowska-Stolarska, M., S. Alivernini, L.E. Ballantine, D.L. Asquith, N.L. Millar, D.S. Gilchrist, J. Reilly, et al. 2011. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proceedings of the National Academy of Sciences of the United States of America 108: 11193–11198. doi:10.​1073/​pnas.​1019536108.CrossRefPubMedPubMedCentral
28.
go back to reference Emelianov, V.U., F.G. Bechara, R. Gläser, E.A. Langan, W.M. Taungjaruwinai, J.M. Schröder, K.C. Meyer, and R. Paus. 2012. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. The British Journal of Dermatology 166: 1023–1034. doi:10.1111/j.1365-2133.2011.10765.x.CrossRefPubMed Emelianov, V.U., F.G. Bechara, R. Gläser, E.A. Langan, W.M. Taungjaruwinai, J.M. Schröder, K.C. Meyer, and R. Paus. 2012. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. The British Journal of Dermatology 166: 1023–1034. doi:10.​1111/​j.​1365-2133.​2011.​10765.​x.CrossRefPubMed
29.
go back to reference van der Zee, H.H., L. de Ruiter, D.G. van den Broecke, W.A. Dik, J.D. Laman, and E.P. Prens. 2011. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. The British Journal of Dermatology 164: 1292–1298. doi:10.1111/j.1365-2133.2011.10254.x.CrossRefPubMed van der Zee, H.H., L. de Ruiter, D.G. van den Broecke, W.A. Dik, J.D. Laman, and E.P. Prens. 2011. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. The British Journal of Dermatology 164: 1292–1298. doi:10.​1111/​j.​1365-2133.​2011.​10254.​x.CrossRefPubMed
30.
go back to reference van der Zee, H.H., J.D. Laman, L. de Ruiter, W.A. Dik, and E.P. Prens. 2012. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. The British Journal of Dermatology 166: 298–305. doi:10.1111/j.1365-2133.2011.10698.x.CrossRefPubMed van der Zee, H.H., J.D. Laman, L. de Ruiter, W.A. Dik, and E.P. Prens. 2012. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. The British Journal of Dermatology 166: 298–305. doi:10.​1111/​j.​1365-2133.​2011.​10698.​x.CrossRefPubMed
31.
go back to reference Gulliver, W., C.C. Zouboulis, E. Prens, G.B.E. Jemec, and T. Tzellos. 2016. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Reviews in Endocrine & Metabolic Disorders. doi:10.1007/s11154-016-9328-5. Gulliver, W., C.C. Zouboulis, E. Prens, G.B.E. Jemec, and T. Tzellos. 2016. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Reviews in Endocrine & Metabolic Disorders. doi:10.​1007/​s11154-016-9328-5.
32.
go back to reference Sonkoly, E., P. Janson, M.-L. Majuri, T. Savinko, N. Fyhrquist, L. Eidsmo, N. Xu, et al. 2010. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. The Journal of Allergy and Clinical Immunology 126: 581–589.e1–20. doi:10.1016/j.jaci.2010.05.045.CrossRefPubMed Sonkoly, E., P. Janson, M.-L. Majuri, T. Savinko, N. Fyhrquist, L. Eidsmo, N. Xu, et al. 2010. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. The Journal of Allergy and Clinical Immunology 126: 581–589.e1–20. doi:10.​1016/​j.​jaci.​2010.​05.​045.CrossRefPubMed
34.
go back to reference Kelly, G., R. Hughes, T. McGarry, M. van den Born, K. Adamzik, R. Fitzgerald, C. Lawlor, A.M. Tobin, C.M. Sweeney, and B. Kirby. 2015. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. The British Journal of Dermatology 173: 1431–1439. doi:10.1111/bjd.14075.CrossRefPubMed Kelly, G., R. Hughes, T. McGarry, M. van den Born, K. Adamzik, R. Fitzgerald, C. Lawlor, A.M. Tobin, C.M. Sweeney, and B. Kirby. 2015. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. The British Journal of Dermatology 173: 1431–1439. doi:10.​1111/​bjd.​14075.CrossRefPubMed
36.
37.
go back to reference Hessam, S., M. Sand, D. Georgas, A. Anders, and F.G. Bechara. 2016. Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa Lesions. Skin Pharmacology and Physiology 29: 161–167. doi:10.1159/000446812.CrossRefPubMed Hessam, S., M. Sand, D. Georgas, A. Anders, and F.G. Bechara. 2016. Microbial Profile and Antimicrobial Susceptibility of Bacteria Found in Inflammatory Hidradenitis Suppurativa Lesions. Skin Pharmacology and Physiology 29: 161–167. doi:10.​1159/​000446812.CrossRefPubMed
39.
go back to reference Hotz, C., M. Boniotto, A. Guguin, M. Surenaud, F. Jean-Louis, P. Tisserand, N. Ortonne, et al. 2016. Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa. Journal of Investigative Dermatology 136: 1768–1780. doi:10.1016/j.jid.2016.04.036.CrossRefPubMed Hotz, C., M. Boniotto, A. Guguin, M. Surenaud, F. Jean-Louis, P. Tisserand, N. Ortonne, et al. 2016. Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa. Journal of Investigative Dermatology 136: 1768–1780. doi:10.​1016/​j.​jid.​2016.​04.​036.CrossRefPubMed
40.
go back to reference Tzanetakou, V., T. Kanni, S. Giatrakou, A. Katoulis, E. Papadavid, M.G. Netea, C.A. Dinarello, J.W.M. van der Meer, D. Rigopoulos, and E.J. Giamarellos-Bourboulis. 2016. Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial. JAMA Dermatology 152: 52–59. doi:10.1001/jamadermatol.2015.3903.CrossRefPubMed Tzanetakou, V., T. Kanni, S. Giatrakou, A. Katoulis, E. Papadavid, M.G. Netea, C.A. Dinarello, J.W.M. van der Meer, D. Rigopoulos, and E.J. Giamarellos-Bourboulis. 2016. Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial. JAMA Dermatology 152: 52–59. doi:10.​1001/​jamadermatol.​2015.​3903.CrossRefPubMed
41.
go back to reference Guinea-Viniegra, J., M. Jiménez, H.B. Schonthaler, R. Navarro, Y. Delgado, M.J. Concha-Garzón, E. Tschachler, S. Obad, E. Daudén, and E.F. Wagner. 2014. Targeting miR-21 to treat psoriasis. Science Translational Medicine 6: 225re1. doi:10.1126/scitranslmed.3008089.CrossRefPubMed Guinea-Viniegra, J., M. Jiménez, H.B. Schonthaler, R. Navarro, Y. Delgado, M.J. Concha-Garzón, E. Tschachler, S. Obad, E. Daudén, and E.F. Wagner. 2014. Targeting miR-21 to treat psoriasis. Science Translational Medicine 6: 225re1. doi:10.​1126/​scitranslmed.​3008089.CrossRefPubMed
42.
go back to reference Murugaiyan, Gopal, A.P. da Cunha, A.K. Ajay, N. Joller, L.P. Garo, S. Kumaradevan, N. Yosef, V.S. Vaidya, and H.L. Weiner. 2015. MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation 125: 1069–1080. doi:10.1172/JCI74347.CrossRefPubMedPubMedCentral Murugaiyan, Gopal, A.P. da Cunha, A.K. Ajay, N. Joller, L.P. Garo, S. Kumaradevan, N. Yosef, V.S. Vaidya, and H.L. Weiner. 2015. MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation 125: 1069–1080. doi:10.​1172/​JCI74347.CrossRefPubMedPubMedCentral
44.
go back to reference Pivarcsi, A., F. Meisgen, N. Xu, M. Ståhle, and E. Sonkoly. 2013. Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy. The British Journal of Dermatology 169: 563–570. doi:10.1111/bjd.12381.CrossRefPubMed Pivarcsi, A., F. Meisgen, N. Xu, M. Ståhle, and E. Sonkoly. 2013. Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy. The British Journal of Dermatology 169: 563–570. doi:10.​1111/​bjd.​12381.CrossRefPubMed
Metadata
Title
Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa
Authors
S. Hessam
M. Sand
M. Skrygan
T. Gambichler
F. G. Bechara
Publication date
01-04-2017
Publisher
Springer US
Published in
Inflammation / Issue 2/2017
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0492-2

Other articles of this Issue 2/2017

Inflammation 2/2017 Go to the issue